No price history available.
Key financial summary
Financials in NZD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | NZDm | 1,281 | 1,059 | 859 | 1,192 | 2,995 | 3,347 | 2,946 | N/A | N/A |
| Operating profit | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | NZDm | 241 | -49 | 1,169 | 643 | 854 | -286 | 550 | N/A | N/A |
| EPS reported | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | NZDm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | NZD | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in NZD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Based in Wellington, New Zealand, Infratil Limited, established in 1994, is an investment company that acquires and manages infrastructure assets across diverse geographies, including New Zealand, Australia, the United States, Asia, the United Kingdom, and Europe. The company plays a significant role in the energy sector, supplying electricity to commercial and industrial clients, and developing, owning, and generating renewable power. This includes the establishment of utility-scale wind and solar generation projects, notably across North America, alongside solar PV energy solutions and battery storage. Its operations encompass 27 hydroelectric power stations with a total installed capacity of 498 MW. In the digital realm, Infratil delivers outsourced data center services to both governmental and private enterprises, in addition to developing and operating its own data centers. It also offers telecommunications services, such as mobile subscriptions, broadband connectivity, and television access. Beyond these, its portfolio extends to the ownership and management of commercial real estate holdings, the operation of retirement living facilities, the running of an airport, and the provision of financial services. Within the healthcare sector, Infratil provides advanced diagnostic imaging services, including x-rays, ultrasound, CT scans, PET scans, and MRIs, which are crucial for the prevention, accurate diagnosis, and treatment of a broad spectrum of health conditions, encompassing cardiovascular, musculoskeletal, respiratory, neurological, kidney, gastrointestinal issues, and various forms of cancer.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Based in Wellington, New Zealand, Infratil Limited, established in 1994, is an investment company that acquires and manages infrastructure assets across diverse geographies, including New Zealand, Australia, the United States, Asia, the United Kingdom, and Europe. The company plays a significant role in the energy sector, supplying electricity to commercial and industrial clients, and developing, owning, and generating renewable power. This includes the establishment of utility-scale wind and solar generation projects, notably across North America, alongside solar PV energy solutions and battery storage. Its operations encompass 27 hydroelectric power stations with a total installed capacity of 498 MW. In the digital realm, Infratil delivers outsourced data center services to both governmental and private enterprises, in addition to developing and operating its own data centers. It also offers telecommunications services, such as mobile subscriptions, broadband connectivity, and television access. Beyond these, its portfolio extends to the ownership and management of commercial real estate holdings, the operation of retirement living facilities, the running of an airport, and the provision of financial services. Within the healthcare sector, Infratil provides advanced diagnostic imaging services, including x-rays, ultrasound, CT scans, PET scans, and MRIs, which are crucial for the prevention, accurate diagnosis, and treatment of a broad spectrum of health conditions, encompassing cardiovascular, musculoskeletal, respiratory, neurological, kidney, gastrointestinal issues, and various forms of cancer.
